BIODYNE (314930) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, BIODYNE (314930) reported revenue of 7.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20257.0 billion KRW652 million KRW852 million KRW[source]
20245.3 billion KRW-1.7 billion KRW11 million KRW[source]
20234.1 billion KRW-2.1 billion KRW-992 million KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202544.8 billion KRW715 million KRW44.1 billion KRW[source]
202444.3 billion KRW1.1 billion KRW43.2 billion KRW[source]
202344.0 billion KRW604 million KRW43.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice